After the silencing of CD133 gene in TGF-β treated hepatoma cells, there was a dramatic reduction in mesenchymal properties as well as an increment in epithelial characteristics, clearly indicating that the gain of mesenchymal features in these cells is attributed to increase in the expression of stemness-associated marker, CD133. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.